Intuitive Surgical (ISRG) announced its most recent quarterly financial results on Tuesday, Oct-18-2016. ISRG said it had a profit of $6.19 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $1.03. Analysts had a consensus of $5.16. The company posted revenue of $682.90 million in the period, compared to analysts expectations of $651.06 million. ISRG’s revenue was up 15.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.24 EPS.
Many Wall Street Analysts have commented on Intuitive Surgical. Intuitive Surgical was Initiated by Wells Fargo to “Outperform” on Oct 13, 2016. Northland Capital Downgraded Intuitive Surgical on Jul 21, 2016 to ” Under Perform”, Price Target of the shares are set at $600.
Intuitive Surgical opened for trading at $718.58 and hit $718.58 on the upside on Friday, eventually ending the session at $714.91, with a gain of 0.21% or 1.47 points. The heightened volatility saw the trading volume jump to 2,11,909 shares. Company has a market cap of $27,519 M.
In a different news, on Aug 24, 2016, Mark J Meltzer (SVP General Counsel & CCO) sold 3,000 shares at $688.33 per share price. According to the SEC, on Aug 5, 2016, Alan J Levy (director) sold 3,188 shares at $694.11 per share price. On Aug 2, 2016, Gary S Guthart (President & CEO) sold 13,400 shares at $698.00 per share price, according to the Form-4 filing with the securities and exchange commission.
Intuitive Surgical Inc. designs manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control range of motion tissue manipulation and three-dimensional (3-D) high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System the da Vinci Si Surgical System the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery gynecologic surgery general surgery cardiothoracic surgery and head and neck surgery.